Applied Clinical Trials podcast

ACT Brief: Zip Code Trial Access, Smaller Biotech APAC Perceptions, and Pimjetmi Tumor Approval

0:00
1:30
Spol 15 sekunder tilbage
Spol 15 sekunder frem
In today’s ACT Brief, we examine how ZIP code shapes trial availability and enrollment, why smaller biotechs hold outdated views of APAC sites, and how FDA approved Pimjetmi for symptomatic tenosynovial giant cell tumor.

Flere episoder fra "Applied Clinical Trials"